PCVX (Vaxcyte) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PCVX Vaxcyte Inc PCVX
34 GF Score
Price $55.96
! 2 Warning Signs
View Full Analysis

What is Vaxcyte Short-term investments?

Short-term investments only applies to insurance companies.

PCVX
34GF Score
Vaxcyte Inc PCVX
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxcyte Business Description

Other Exchanges 1PCVX:Italy5VA:Germany
Address 825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
34GF Score

Get the complete analysis for PCVX

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$55.96
Price